INTERVENTIONAL VASCULAR CORPORATE PRESS RELEASES

Please find below a list of our press releases.

9 Jan 2017

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS®...

BTG plc (LSE: BTG), the global specialist healthcare company, today announced the first patients diagnosed with Pulmonary Embolism (PE) to be treated in Hong Kong using the newly available EKOS® system.

9 Jul 2015

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment ...

EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multicenter randomized trial that compares ultrasound-accelerated, catheter-directed thrombolysis (USAT) to standard side-hole catheter-directed thrombolysis (CDT) for the treatment of acute peripheral arterial thrombotic occlusions

11 Jun 2014

EKOS Initiates a Pivotal New Study in Patients with Chronic...

ACCESS PTS study aims to evaluate the safety and efficacy of Ultrasound Accelerated Thrombolysis with standard thrombolytic infusion for treatment of Post-Thrombotic Syndrome

23 May 2014

EkoSonic Endovascular System receives FDA Clearance for the...

EkoSonic Endovascular System receives FDA Clearance for the Treatment of Pulmonary Embolism in the USA

30 Mar 2014

Acute Pulmonary Embolism Trial Confirms Safety and Efficacy of Ultrasound Acc...

Results show no intracranial hemorrhage and extended survival among patients at high risk of death